Skip to main content
. 2020 Jan 24;72(4):586–594. doi: 10.1093/cid/ciaa076

Figure 2.

Figure 2.

Growth outcomes of children who were human immunodeficiency virus (HIV) exposed but uninfected (CHEU) and children who were HIV unexposed (CHU) through 18 months of age. Length-for-age (A), weight-for-age (B), weight-for-length (E), and head circumference-for-age (F) z score growth trajectories in CHEU and CHU through 18 months. Data points are z score with 95% confidence intervals (CIs). Stunting (C), underweight (D), wasting (G), and microcephaly (H) in CHEU and CHU through 18 months. Data points are point prevalence percentages with 95% CIs. Number of children (CHEU/CHU) at each timepoint for length-for-age z score (A) and stunting (C): 176/1014 at 1 month, 116/1061 at 3 months, 215/1231 at 6 months, 220/1318 at 12 months, and 297/1771 at 18 months; weight-for-age z score (B) and underweight (D): 175/991 at Figure 2. Continued. 1 month, 160/1049 at 3 months, 217/1216 at 6 months, 221/1308 at 12 months, and 297/1765 at 18 months; weight-for-length (E) and wasting (G): 175/984 at 1 month, 159/1044 at 3 months, 215/1212 at 6 months, 220/1304 at 12 months, and 295/1762 at 18 months; head circumference-for-age z score (F) and microcephaly (H): 169/1038 at 3 months, 214/1232 at 6 months, 221/1321 at 12 months, and 296/1757 at 18 months (there was no head circumference measurement at 1 month of age). Stunting: length-for-age z score < −2; underweight: weight-for-age z score < −2; wasting: weight-for-length z score < −2; microcephaly: head circumference-for-age z score < −2. Only children in non–infant and young child feeding trial arms were included. *P < .05, **P < .01, ***P < .001. Full details including CIs appear in Supplementary Table 5.